383 A/C tumor necrosis factor receptor 1 polymorphism and ankylosing spondylitis in Mexicans: A preliminary study

Rheumatology International

Volumn 32, Issue 8, 2012, Pages 2565-2568

  Corona Sanchez, Esther Guadalupe ^a,b   Muñoz Valle, José Francisco ^b   Gonzalez Lopez, Laura ^b,c   Sanchez Hernandez, Julia Dolores ^a   Mercado, Monica Vazquez Del ^b   Ontiveros Mercado, Heriberto ^a   Huerta, Miguel ^d   Trujillo, Xochitl ^d   Rocha Muñoz, Alberto Daniel ^c   Celis, Alfredo ^b   Ortega Flores, Ricardo ^c   Gamez Nava, Jorge Ivan ^a,e  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d Centro Universitario de Investigaciones Biomédicas   (Mexico)

^e Centro Universitario de Investigaciones Biomédicas ^*  (Mexico)

Author keywords

Ankylosing spondylitis; Case control studies; Genetic polymorphism; Tumor necrosis factor receptor 1

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENDER; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEXICO; POLYMERASE CHAIN REACTION; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAMPLE SIZE;

EID: 84866245028     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1997-5     Document Type: Article

References (18)

1. Khan MA (1998) Ankylosing spondylitis: clinical aspects. In: Calin A, Taurog JD (eds) The spondylarthritides. Oxford University, Oxford, pp 27-40
2. Liu Y, Cortinovis D, Stone MA (2004) Recent advances in the treatment of the spondyloarthropathies. Curr Opin Rheumatol 16:357-365
3. Glossop JR, Dawes PT, Nixon NB, Mattey DL (2005) Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Arthritis Res Ther 7:R1227-R1234
4. Dieudé P, Osorio J, Petit-Teixeira E et al (2004) A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum 50:413-419
5. Glossop JR, Nixon NB, Dawes PT, Hassell AB, Mattey DL (2003) No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis. J Rheumatol 30:1406-1409
6. Pitts SA, Olomolaiye OO, Elson CJ, Westacott CI, Bidwell JL (1998) Identification of a rare Bg/II polymorphism in the promoter region of the human TNF receptor type I(p55) gene. Eur J Immunogenet 25:271-272
7. Nishimura M, Obayashi H, Mizuta I et al (2003) TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol 64:302-309
8. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361-368
9. Vargas-Alarcon G, Casasola-Vargas J, Rodríguez-Pérez JM et al (2006) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 67:826-832
10. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286-2291
11. Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281-2285
12. Daltroy LH, Larson MG, Roberts NW, Liang MH (1990) A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 17:946-950
13. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
14. Davis JC Jr (2005) Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis. Semin Arthritis Rheum 34:668-677
15. Bridges SL Jr, Jenq G, Moran M, Kuffner T, Whitworth WC, McNicholl J (2002) Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences. Arthritis Rheum 46:2045-2050
16. Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA (2009) The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol 27:645-648
17. Australo-Anglo-American Spondyloarthritis Consortium, TASC (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42:123-127
18. Davidson SI, Liu Y, Danoy PA et al (2011) Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis 70:289-292